Patient Pathfinder: Clinical Trials

Clinical Trial Finder Myelodysplastic Syndrome Trials

Clinical Trials for Myelodysplastic Syndrome

Every life-saving or life-extending treatment that's available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.

Clinical trials also give patients a chance to try a treatment before it's approved by the U.S. Food and Drug Administration.

See Locations Near You

What’s the Standard Treatment for MDS (Myelodysplastic Syndrome)?

There are 164 active Myelodysplastic Syndrome trials

Revlimid in Transfusion Dependent Patients

Study Type: Interventional Phase 2

Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia

Study Type: Interventional Phase 1

US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

Study Type: Interventional Phase 2

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

Study Type: Observational

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Study Type: Interventional Phase 1

Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Study Type: Interventional Phase 2

Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS

Study Type: Interventional Phase 1

Inqovi Maintenance Therapy in Myeloid Neoplasms

Study Type: Interventional Phase 1

« Previous 1 … 18 19 20 21 Next »

There are 164 active Myelodysplastic Syndrome trials

Filter Results

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.

Need more help finding a clinical trial that's the right fit?

Explore our Clinical Trial Finder.